Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Mehta
Francis Y Yao

Showing results (1-10 of 342) with videos related to

Pageof 35
Sort By:
Gastroenterology|December 17, 2016
Transarterial Radioembolization for Hepatocellular Carcinoma: Who, When… and Y(90)?Neil Mehta, Francis Y Yao
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 13, 2017
Con: Treating hepatitis C virus With direct-acting antivirals: Fear not the perceived threat of hepatocellular carcinomaNeil Mehta, Francis Y Yao
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 16, 2021
Liver Transplantation After Downstaging of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Using Yttrium-90 Radioembolization: Pipe Dream or Reality?Neil Mehta, Francis Y Yao
Hepatology (Baltimore, Md.)|June 26, 2020
ReplyNeil Mehta, Francis Y Yao
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 21, 2013
Moving past "One size (and number) fits all" in the selection of candidates with hepatocellular carcinoma for liver transplantationNeil Mehta, Francis Y Yao
Hepatology (Baltimore, Md.)|December 19, 2015
Nucleos(t)ide analogs reduce the risk of hepatitis B-associated hepatocellular carcinoma: A can't miss proposition?Neil Mehta, Francis Y Yao
Current Opinion in Organ Transplantation|January 26, 2016
Hepatocellular cancer as indication for liver transplantation: pushing beyond MilanNeil Mehta, Francis Y Yao
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 20, 2018
Living donor liver transplantation for hepatocellular carcinoma: To expand (beyond Milan) or downstage (to Milan)?Neil Mehta, Francis Y Yao
Clinical Liver Disease|June 7, 2019
What Are the Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma?Neil Mehta, Francis Y Yao
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 21, 2016
ReplyNeil Mehta, Francis Y Yao
Pageof 35

Showing results (1-10 of 342) with videos related to

Sort By:
Pageof 35
Gastroenterology|December 17, 2016
Transarterial Radioembolization for Hepatocellular Carcinoma: Who, When… and Y(90)?Neil Mehta, Francis Y Yao
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 13, 2017
Con: Treating hepatitis C virus With direct-acting antivirals: Fear not the perceived threat of hepatocellular carcinomaNeil Mehta, Francis Y Yao
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 16, 2021
Liver Transplantation After Downstaging of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Using Yttrium-90 Radioembolization: Pipe Dream or Reality?Neil Mehta, Francis Y Yao
Hepatology (Baltimore, Md.)|June 26, 2020
ReplyNeil Mehta, Francis Y Yao
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 21, 2013
Moving past "One size (and number) fits all" in the selection of candidates with hepatocellular carcinoma for liver transplantationNeil Mehta, Francis Y Yao
Hepatology (Baltimore, Md.)|December 19, 2015
Nucleos(t)ide analogs reduce the risk of hepatitis B-associated hepatocellular carcinoma: A can't miss proposition?Neil Mehta, Francis Y Yao
Current Opinion in Organ Transplantation|January 26, 2016
Hepatocellular cancer as indication for liver transplantation: pushing beyond MilanNeil Mehta, Francis Y Yao
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 20, 2018
Living donor liver transplantation for hepatocellular carcinoma: To expand (beyond Milan) or downstage (to Milan)?Neil Mehta, Francis Y Yao
Clinical Liver Disease|June 7, 2019
What Are the Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma?Neil Mehta, Francis Y Yao
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 21, 2016
ReplyNeil Mehta, Francis Y Yao
Pageof 35